Media

«A 7 ans, je voulais déjà être scientifique»

TECHNOLOGIES MÉDICALES En 2019, seulement une société sur quatre était fondée par une femme. A la tête de la start-up zurichoise CUTISS, qui veut révolutionner la greffe pour grands brûlés, Daniela Marino prouve que l’esprit d’entreprise se décline très bien au féminin.

Read full article by following the link below.

The Limmattaler Newspaper visited Vincent Ronfard, our Chief Innovation Officer in our lab in Schlieren. Read about CUTISS’ Research and Development in the field of skin manufacturing.
(article in German only).

“Die Fragen gehen ihm nie aus:
Vincent Ronfard forscht seit 30 Jahren, heute züchtet er für das Schlieremer Start-up Cutiss Haut für Brandwunden…”

The Swiss company Cutiss produces new skin for patients with scars or deep burns. The CEO is currently raising money to build up the production. (Article in German only)

“Sie geben Brandopfern Hoffnung: Die Schweizer Firma Cutiss züchtet neue Haut für Patienten mit Narben oder schweren Verbrennungen. Die Chefin sucht jetzt frisches Geld für den Aufbau der Produktion…”

Read the media coverage in the Handelszeitung about CUTISS broadening our Management Team.
(German only)

Read about CUTISS growing skin in the latest edition of FORBES no. 9 / 2019
(This article is only available in German.)

“Ein briefmarkengroßes Stück Haut
innerhalb eines Monats um das
Siebzigfache vergrößern – bei Cutiss
ist das Realität. Das Life-Science Unternehmen aus Zürich arbeitet an
einer innovativen Art der Hauttransplantation, der Denovoskin-Technologie…”

Read about CUTISS in the Swiss Health Insurer Sanitas’ Magazine:

Our body is covered with around 1.7 square metres of skin. If this protection is missing, for example due to extensive burns, reserve skin is needed for skin grafts within a short period of time. Zurich-based start-up Cutiss has developed a new process to bio-engineer the required skin…

Switzerland is perfect for Startups, but… Switzerland boasts some of the best skills in the world, according to Daniela Marino. The Cutiss CEO says Switzerland is also the “perfect place” to be an entrepreneur. So what’s the catch? When it comes to money, Swiss investors aren’t as willing to take risks as their American counterparts.

Interview mit Daniela Marino auf CNN Money Switzerland.

“The B round will need to provide 30-40 million CHF to support the market access.”

by Patrick Gunti

Moneycab.com: Ms. Marino, Cutiss has developed a revolutionary method to produce human skin in the lab. How did that happen?
In 2001 the Tissue Biology Reseach Unit, a research lab of the Department of Surgery of the University Children’s hospital in Zurich started working on skin bio-engineering to solve an unmet clinical need mostly connected to burns. Unfortunately, standard of care to treat large, deep burns is scarce and ineffective leading very often to highly debilitating, disfiguring scarring. Via personalized skin tissue bio-engineering one could permanently treat large wound surfaces and minimize the scarring.

Article in French only.

Start-up suisse créée en 2017 et spécialisée dans la biotechnologie, CUTISS AG est une jeune entreprise adossée à l’Université de Zürich. Son application ? La peau ! Spécialisée dans la reconstitution de peau sur-mesure, Cutiss travaille main dans la main avec des hôpitaux européens, Suisses, Hollandais et Anglais, et travaille déjà à son futur : démocratiser la fabrication de peau pour les grands blessés et pour toutes les autres personnes ayant besoin d’une greffe de peau.